Lab Tested Products
SP-3RT
SP-3RT is a synthetic research compound intended for controlled laboratory use. Researchers work with this material in in vitro settings where defined structure, consistency, and reliable handling are essential.
- Enables single-compound study of GLP-1, GIP, and glucagon receptor engagement
- Designed for research examining coordinated signaling across multiple receptor pathways
- Offers a defined approach to studying complex receptor interaction in controlled system
SP-3RT/Cag
SP-3RT/Cag is a research peptide combination supplied for controlled laboratory studies. Researchers use this formulation in structured research focused on peptide signaling and interaction behavior.
- Combination peptide formulation for laboratory research
- Supports studies focused on peptide signaling and interaction models
- Suitable for controlled and repeatable research workflows
Tesamorelin 10MG
Tesamorelin is a synthetic research peptide supplied for controlled laboratory studies. Researchers use this compound in structured research focused on peptide signaling and sequence behavior.
- Synthetic peptide designed for laboratory research applications
- Used in studies focused on peptide signaling and structure
- Suitable for controlled and repeatable research workflows
Tesofensine
Tesofensine is a research compound supplied for controlled laboratory studies. Researchers use this compound in structured research focused on signaling behavior and molecular interaction models.
- Small-molecule research compound for laboratory investigation
- Used in studies focused on signaling pathways and interaction behavior
- Suitable for controlled and repeatable research workflows
Ultra-RT Ultratrutide™
Ultra-RT Ultratrutide™ is an advanced experimental quad-agonist peptide developed for metabolic pathway research, combining GLP-1, GIP, Glucagon, and Ghrelin receptor activity into a single innovative research compound designed to explore body composition, energy utilization, and lean tissue signaling pathways.
- Advanced quad-agonist targeting four metabolic receptor pathways
- Combines GLP-1, GIP, Glucagon, and Ghrelin receptor activity
- Designed for body composition and metabolic pathway research
- Supports investigation of lean tissue signaling mechanisms
- Innovative next-generation research peptide architecture
